Editorial comment.
Marc B
MB
Garnick
D000740:Anemia / Q000401:mortality / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control; D011300:Preoperative Care / Q000379:methods; D011379:Prognosis; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods*; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality* / Q000601:surgery*; D011994:Recombinant Proteins; D018570:Risk Assessment; D016019:Survival Analysis; D013923:Thromboembolism / Q000209:etiology / Q000401:mortality
D011994:Recombinant Proteins; D004921:Erythropoietin